ISRCTN50493318已完成未知
A double-blind, multicentre, international randomised study to assess the effects of 6 months or 12 months administration of strontium ranelate versus biphosphonates on bone remodelling and bone safety assessed by histomorphometry in women with postmenopausal osteoporosis
Institut de Recherches Internationales Servier (France)0 个研究点目标入组 387 人开始时间: 2007年7月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 387
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Women of at least 50 years of age
- •2. Postmenopausal for at least three years
- •3. Osteoporosis
排除标准
- •1. Any medical or anatomical condition that potentially could put the patient at additional risk of an adverse event due to the biopsy procedure or that potentially could lead to an impossibility to perform a transiliac bone biopsy on each side
- •2. Previous and concomitant treatments interfering with bone metabolism
研究者
相似试验
进行中（未招募）
不适用
A double-blind, multicenter, international randomised study to assess the effects of 6 months or 12 months administration of 2g per day of strontium ranelate versus alendronate 70mg per week on bone remodelling and bone safety assessed by histomorphometry in women with postmenopausal osteoporosisTreatment of postmenopausal Osteoporosis to reduce the risk of hip and vertebral fracturesMedDRA version: 9.1Level: PTClassification code 10031285Term: Osteoporosis postmenopausalEUCTR2006-005581-39-DKInstitut de Recherches Internationales Servier285
进行中（未招募）
不适用
Effects of strontium ranelate on bone quality before dental implantatioDental implantation in osteoporotic patients or in patients at risk of osteoporotic fractureMedDRA version: 14.1Level: PTClassification code 10064143Term: Dental implantationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2011-002370-23-DEInstitut de Recherches Internationales Servier60
进行中（未招募）
不适用
A double-blind, multicenter, international randomised study to assess the effects of 6 months or 12 months administration of 2g per day of strontium ranelate versus alendronate 70mg per week on bone remodelling and bone safety assessed by histomorphometry in women with postmenopausal osteoporosisTreatment of postmenopausal Osteoporosis to reduce the risk of hip and vertebral fracturesMedDRA version: 9.1Level: PTClassification code 10031285Term: Osteoporosis postmenopausalEUCTR2006-005581-39-NLInstitut de Recherches Internationales Servier285
进行中（未招募）
不适用
A double-blind, multicenter, international randomised study to assess the effects of 6 months or 12 months administration of 2g per day of strontium ranelate versus alendronate 70mg per week on bone remodelling and bone safety assessed by histomorphometry in women with postmenopausal osteoporosisTreatment of postmenopausal Osteoporosis to reduce the risk of hip and vertebral fracturesMedDRA version: 9.1Level: PTClassification code 10031285Term: Osteoporosis postmenopausalEUCTR2006-005581-39-BEInstitut de Recherches Internationales Servier285
进行中（未招募）
不适用
A double-blind, multicenter, international randomised study to assess the effects of 6 months or 12 months administration of 2g per day of strontium ranelate versus alendronate 70mg per week on bone remodelling and bone safety assessed by histomorphometry in women with postmenopausal osteoporosis - ISRCTN50493318Treatment of postmenopausal Osteoporosis to reduce the risk of hip and vertebral fracturesMedDRA version: 9.1Level: PTClassification code 10031285Term: Osteoporosis postmenopausalEUCTR2006-005581-39-EEInstitut de Recherches Internationales Servier285